Insider Trading Alert - XRAY, PLD And CLX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 3, 2014, 66 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $710.62 to $347,575,500.00.

Highlighted Stocks Traded by Insiders:

DENTSPLY International (XRAY) - FREE Research Report

Sterkenburg Albert, who is Senior VP at DENTSPLY International, sold 2,000 shares at $50.51 on Nov. 3, 2014. Following this transaction, the Senior VP owned 8,440 shares meaning that the stake was reduced by 19.16% with the 2,000-share transaction.

The shares most recently traded at $50.76, up $0.25, or 0.49% since the insider transaction. Historical insider transactions for DENTSPLY International go as follows:

  • 4-Week # shares sold: 2,000
  • 12-Week # shares sold: 2,000
  • 24-Week # shares sold: 4,764

The average volume for DENTSPLY International has been 727,100 shares per day over the past 30 days. DENTSPLY International has a market cap of $7.2 billion and is part of the health care sector and health services industry. Shares are up 4.6% year-to-date as of the close of trading on Monday.

DENTSPLY International Inc. designs, develops, manufactures, and markets various consumable dental products for the professional dental market worldwide. The stock currently has a dividend yield of 0.52%. The company has a P/E ratio of 23.5. Currently, there are 5 analysts who rate DENTSPLY International a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on XRAY - FREE

TheStreet Quant Ratings rates DENTSPLY International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, good cash flow from operations, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full DENTSPLY International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Prologis (PLD) - FREE Research Report

Palazzolo Lori A, who is Chief Accounting Officer/MD at Prologis, sold 1,340 shares at $40.77 on Nov. 3, 2014. Following this transaction, the Chief Accounting Officer/MD owned 16,328 shares meaning that the stake was reduced by 7.58% with the 1,340-share transaction.

The shares most recently traded at $41.54, up $0.77, or 1.84% since the insider transaction. Historical insider transactions for Prologis go as follows:

  • 4-Week # shares sold: 14,800
  • 12-Week # shares sold: 14,800
  • 24-Week # shares sold: 58,800

The average volume for Prologis has been 2.4 million shares per day over the past 30 days. Prologis has a market cap of $20.8 billion and is part of the financial sector and real estate industry. Shares are up 13.21% year-to-date as of the close of trading on Monday.

Prologis Inc. is an independent equity real estate investment trust. It invests in the real estate markets across the globe. The firm engages in the ownership, development, management, and leasing of industrial distribution and retail properties. The stock currently has a dividend yield of 3.17%. The company has a P/E ratio of 143.6. Currently, there are 13 analysts who rate Prologis a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PLD - FREE

TheStreet Quant Ratings rates Prologis as a hold. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income and notable return on equity. However, as a counter to these strengths, we find that the company's profit margins have been poor overall. Get the full Prologis Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Clorox (CLX) - FREE Research Report

Tataseo Frank A, who is EVP - Prof. Products Div. at Clorox, sold 1,363 shares at $98.04 on Nov. 3, 2014. Following this transaction, the EVP - Prof. Products Div. owned 11,581 shares meaning that the stake was reduced by 10.53% with the 1,363-share transaction.

The shares most recently traded at $101.11, up $3.07, or 3.04% since the insider transaction. Historical insider transactions for Clorox go as follows:

  • 4-Week # shares sold: 2,505
  • 12-Week # shares sold: 5,971
  • 24-Week # shares sold: 6,090

The average volume for Clorox has been 1.1 million shares per day over the past 30 days. Clorox has a market cap of $12.9 billion and is part of the consumer goods sector and consumer durables industry. Shares are up 7.62% year-to-date as of the close of trading on Monday.

The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates in four segments: Cleaning, Household, Lifestyle, and International. The stock currently has a dividend yield of 2.97%. The company has a P/E ratio of 23.1. Currently, there is 1 analyst who rates Clorox a buy, 6 analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CLX - FREE

TheStreet Quant Ratings rates Clorox as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, expanding profit margins, growth in earnings per share and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Clorox Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists